Pharmaceuticals: Commission refines intellectual property rules

The Commission is proposing a targeted adjustment to intellectual property rules to help Europe's pharmaceutical companies tap into fast-growing global markets and foster jobs, growth and investments in the EU. The EU has a strong intellectual property rights framework in place which protects Europe's know-how and sustains the pharmaceutical industry's world-class innovation capacity. To improve … Continue reading Pharmaceuticals: Commission refines intellectual property rules

How the EU regulates medicines

Awareness session for international regulators and NGOs on the work of EMA and European medicines regulatory system. The European Medicines Agency (EMA) will host an awareness session to present the European Union’s (EU) medicines regulatory system and EMA’s role in it to international regulators and non-governmental organisations. A clear understanding of how medicines are regulated in … Continue reading How the EU regulates medicines